July 2026 marks sixteen years since Interventional Systems was founded with an ambitious goal: that the precision of robotics should be accessible to every patient, in every hospital. Last year we looked back at milestones and timelines; this time, we’ll let the cases speak.
The Micromate™ robotic platform will be integrated into the institute’s minimally invasive surgery training curriculum.
A new multisociety Delphi consensus on procedural and practice standards for liver tumor thermal ablation, published in The Lancet Oncology, directly addresses robotic and stereotactic guidance. For interventional radiologists working with these tools, or considering them, the results are worth unpacking.
Partnership establishes a collaboration framework to combine two FDA-cleared platforms to address unmet needs in robotic navigation.
As part of their Fourth Quarter and Full Year 2025 Financial Results release, Shoulder Innovations (NYSE: SI) publicly highlighted their strategic partnership with Interventional Systems (INS) to develop a shoulder-specific micro-robotic solution for total and reverse shoulder arthroplasty.
We were proud to sponsor the inaugural European Conference on Image-Guided Pain Management (ECIP Summit 2026) in Vienna, a milestone event bringing together a select group of leading interventional radiologists dedicated to advancing image-guided pain therapies.
ATEC Spine has commercially launched Valence, a fully integrated robotic and navigation system for spine surgery.¹ For us at Interventional Systems, this is a milestone worth acknowledging: Valence is built on the miniature robotic technology we developed, which found its way into the spine market through Fusion Robotics and eventually into ATEC’s hands via their acquisition of Accelus in 2023.
In the first week of March, we welcomed our Micromate™ and iFIX distributors to our office in Wattens, Austria, for our annual distributor meeting — three days of product training, knowledge sharing, and collaboration.
The SHERPA research consortium has initiated seven clinical studies to demonstrate the benefits of AI- and robotics-assisted workflows in minimally invasive treatments for brain aneurysms* and liver tumors.
We recently participated at the Spectrum Miami Conference, where we had the opportunity to showcase Micromate™ and connect with leading professionals in interventional radiology and oncology.
Let’s wrap up 2025 by looking back at some of the milestones that shaped the year!
The transformative shoulder-specific micro-robotic solution will be designed to further enhance shoulder surgical precision, workflow efficiency, and enable exciting, new clinical approaches in the total shoulder arthroplasty (TSA) and reverse shoulder arthroplasty (RSA) markets.
